More articles from Minireview

Open Access
Drug Discovery Strategies for SARS-CoV-2
Zeenat A. Shyr, Kirill Gorshkov, Catherine Z. Chen and Wei Zheng

Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 127-138; DOI: https://doi.org/10.1124/jpet.120.000123
You have access
Strategies for developing kappa opioid receptor agonists for the treatment of pain with fewer side-effects
Kelly Paton, Diana Atigari, Sophia Kaska, Thomas E Prisinzano and Bronwyn M Kivell

Journal of Pharmacology and Experimental Therapeutics September 10, 2020, JPET-MR-2020-000134; DOI: https://doi.org/10.1124/jpet.120.000134
You have access
Analgesia with Gabapentin and Pregabalin May Involve N-Methyl-d-Aspartate Receptors, Neurexins, and Thrombospondins
Charles P. Taylor and Eric W. Harris

Journal of Pharmacology and Experimental Therapeutics July 2020, 374 (1) 161-174; DOI: https://doi.org/10.1124/jpet.120.266056
You have access
Pleiotropic and Adverse Effects of Statins—Do Epigenetics Play a Role?
Stephanie C. Allen and Cyril D.S. Mamotte

Journal of Pharmacology and Experimental Therapeutics August 2017, 362 (2) 319-326; DOI: https://doi.org/10.1124/jpet.117.242081
You have access
S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis
Anna Cantalupo and Annarita Di Lorenzo

Journal of Pharmacology and Experimental Therapeutics August 2016, 358 (2) 359-370; DOI: https://doi.org/10.1124/jpet.116.233205
You have access
New Insight into the Dietary Cause of Atherosclerosis: Implications for Pharmacology
Reynold Spector

Journal of Pharmacology and Experimental Therapeutics July 2016, 358 (1) 103-108; DOI: https://doi.org/10.1124/jpet.116.233296
You have access
Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of Nonhuman Primate Studies and Clinical Trials
Philippe Huot, Susan H. Fox and Jonathan M. Brotchie

Journal of Pharmacology and Experimental Therapeutics June 2016, 357 (3) 562-569; DOI: https://doi.org/10.1124/jpet.116.232371
You have access
The Utility of Impulsive Bias and Altered Decision Making as Predictors of Drug Efficacy and Target Selection: Rethinking Behavioral Screening for Antidepressant Drugs
Gerard J. Marek, Mark Day and Thomas J. Hudzik

Journal of Pharmacology and Experimental Therapeutics March 2016, 356 (3) 534-548; DOI: https://doi.org/10.1124/jpet.115.229922
You have access
Protoporphyrin IX: the Good, the Bad, and the Ugly
Madhav Sachar, Karl E. Anderson and Xiaochao Ma

Journal of Pharmacology and Experimental Therapeutics February 2016, 356 (2) 267-275; DOI: https://doi.org/10.1124/jpet.115.228130
You have access
Adverse Outcome Pathways—Organizing Toxicological Information to Improve Decision Making
Stephen W. Edwards, Yu-Mei Tan, Daniel L. Villeneuve, M.E. Meek and Charlene A. McQueen

Journal of Pharmacology and Experimental Therapeutics January 2016, 356 (1) 170-181; DOI: https://doi.org/10.1124/jpet.115.228239

Main menu

User menu

Search

More articles from Minireview

Pages

Navigate

More Information

ASPET's Other Journals